Search research articles
Contact Us
Filters
Showing results (51-60 of 96) with videos related to
Page
of 10
Sort By:
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
October 24, 2012
Long-term follow-up of lung and heart transplant recipients with pre-transplant malignancies
Vilborg Sigurdardottir, Oystein Bjortuft, Hans Eiskjær, et al.
ESC Heart Failure
|
April 2, 2022
Healthcare resource use of patients with transthyretin amyloid cardiomyopathy
Rosa Lauppe, Johan Liseth Hansen, Anna Fornwall, et al.
ESC Heart Failure
|
May 13, 2022
Prevalence, characteristics, and mortality of patients with transthyretin amyloid cardiomyopathy in the Nordic countries
Rosa Lauppe, Johan Liseth Hansen, Anna Fornwall, et al.
American Heart Journal
|
August 21, 2025
DAPAgliflozin for Renal protection in Heart Transplant recipients. Rationale and design of the randomized controlled DAPARHT trial
Stine Holmen, Olivier Manintveld, Kevin Damman, et al.
JAMA Dermatology
|
July 19, 2023
Rates of Second Tumor, Metastasis, and Death From Cutaneous Squamous Cell Carcinoma in Patients With and Without Transplant-Associated Immunosuppression
Petter Gjersvik, Ragnhild S Falk, Ingrid Roscher, et al.
Rheumatology (Oxford, England)
|
December 14, 2017
Frequencies of borderline pulmonary hypertension before and after the DETECT algorithm: results from a prospective systemic sclerosis cohort
Anna-Maria Hoffmann-Vold, Håvard Fretheim, Øyvind Midtvedt, et al.
ACR Open Rheumatology
|
November 29, 2019
Systolic Dysfunction in Systemic Sclerosis: Prevalence and Prognostic Implications
Anders H Tennøe, Klaus Murbræch, Johanna C Andreassen, et al.
Heart (British Cardiac Society)
|
July 18, 2014
Familial globotriaosylceramide-associated cardiomyopathy mimicking Fabry disease
Turid Apelland, Einar Gude, Erik H Strøm, et al.
Clinical Transplantation
|
November 22, 2024
The Effect of Everolimus Versus Calcineurin Inhibitors on Quality of Life 10-12 Years After Heart Transplantation: The Results of a Randomized Controlled Trial (SCHEDULE Trial)
Ingelin Grov, Anne Relbo Authen, Satish Arora, et al.
Clinical Transplantation
|
June 23, 2017
Effect of everolimus vs calcineurin inhibitors on quality of life in heart transplant recipients during a 3-year follow-up: Results of a randomized controlled trial (SCHEDULE)
Anne Relbo Authen, Ingelin Grov, Kristjan Karason, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 96) with videos related to
Sort By:
Page
of 10
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
October 24, 2012
Long-term follow-up of lung and heart transplant recipients with pre-transplant malignancies
Vilborg Sigurdardottir, Oystein Bjortuft, Hans Eiskjær, et al.
ESC Heart Failure
|
April 2, 2022
Healthcare resource use of patients with transthyretin amyloid cardiomyopathy
Rosa Lauppe, Johan Liseth Hansen, Anna Fornwall, et al.
ESC Heart Failure
|
May 13, 2022
Prevalence, characteristics, and mortality of patients with transthyretin amyloid cardiomyopathy in the Nordic countries
Rosa Lauppe, Johan Liseth Hansen, Anna Fornwall, et al.
American Heart Journal
|
August 21, 2025
DAPAgliflozin for Renal protection in Heart Transplant recipients. Rationale and design of the randomized controlled DAPARHT trial
Stine Holmen, Olivier Manintveld, Kevin Damman, et al.
JAMA Dermatology
|
July 19, 2023
Rates of Second Tumor, Metastasis, and Death From Cutaneous Squamous Cell Carcinoma in Patients With and Without Transplant-Associated Immunosuppression
Petter Gjersvik, Ragnhild S Falk, Ingrid Roscher, et al.
Rheumatology (Oxford, England)
|
December 14, 2017
Frequencies of borderline pulmonary hypertension before and after the DETECT algorithm: results from a prospective systemic sclerosis cohort
Anna-Maria Hoffmann-Vold, Håvard Fretheim, Øyvind Midtvedt, et al.
ACR Open Rheumatology
|
November 29, 2019
Systolic Dysfunction in Systemic Sclerosis: Prevalence and Prognostic Implications
Anders H Tennøe, Klaus Murbræch, Johanna C Andreassen, et al.
Heart (British Cardiac Society)
|
July 18, 2014
Familial globotriaosylceramide-associated cardiomyopathy mimicking Fabry disease
Turid Apelland, Einar Gude, Erik H Strøm, et al.
Clinical Transplantation
|
November 22, 2024
The Effect of Everolimus Versus Calcineurin Inhibitors on Quality of Life 10-12 Years After Heart Transplantation: The Results of a Randomized Controlled Trial (SCHEDULE Trial)
Ingelin Grov, Anne Relbo Authen, Satish Arora, et al.
Clinical Transplantation
|
June 23, 2017
Effect of everolimus vs calcineurin inhibitors on quality of life in heart transplant recipients during a 3-year follow-up: Results of a randomized controlled trial (SCHEDULE)
Anne Relbo Authen, Ingelin Grov, Kristjan Karason, et al.
Page
of 10